Class Action Lawsuit Claims LiLash, LiBrow Serums Contain Unsafe Drug Ingredient
September 30, 2026 A class action lawsuit claims that LiLash and LiBrow serums pose serious, undisclosed health risks to consumers due to the inclusion of the ingredient dehydrolatanoprost.